Erratum : Group Testing for SARS-CoV-2 Allows for Up to 10-Fold Efficiency Increase Across Realistic Scenarios and Testing Strategies
Copyright © 2021 Frontiers Production Office..
[This corrects the article DOI: 10.3389/fpubh.2021.583377.].
| Errataetall: |
ErratumFor: Front Public Health. 2021 Aug 18;9:583377. - PMID 34490172 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
Frontiers in public health - 9(2021) vom: 29., Seite 781326 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Frontiers Production Office [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Revised 04.11.2021 published: Electronic-eCollection ErratumFor: Front Public Health. 2021 Aug 18;9:583377. - PMID 34490172 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3389/fpubh.2021.781326 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM332719286 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM332719286 | ||
| 003 | DE-627 | ||
| 005 | 20231225220142.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fpubh.2021.781326 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1109.xml |
| 035 | |a (DE-627)NLM332719286 | ||
| 035 | |a (NLM)34733816 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Frontiers Production Office |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Erratum |b Group Testing for SARS-CoV-2 Allows for Up to 10-Fold Efficiency Increase Across Realistic Scenarios and Testing Strategies |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 04.11.2021 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a ErratumFor: Front Public Health. 2021 Aug 18;9:583377. - PMID 34490172 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2021 Frontiers Production Office. | ||
| 520 | |a [This corrects the article DOI: 10.3389/fpubh.2021.583377.] | ||
| 650 | 4 | |a Published Erratum | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a RT-PCR | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a group testing | |
| 650 | 4 | |a informative testing | |
| 650 | 4 | |a pooling | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in public health |d 2013 |g 9(2021) vom: 29., Seite 781326 |w (DE-627)NLM23377548X |x 2296-2565 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2021 |g day:29 |g pages:781326 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3389/fpubh.2021.781326 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2021 |b 29 |h 781326 | ||